Total Payments
$856.20
2024 Payments
$522.51
Companies
16
Transactions
43
Medicare Patients
1,189
Medicare Billing
$125,831
Payment Breakdown by Category
Food & Beverage$856.20 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $856.20 | 43 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $153.20 | 7 | $0 (2024) |
| Allergan Inc. | $151.92 | 5 | $0 (2018) |
| ABBVIE INC. | $142.12 | 10 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $61.52 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $56.03 | 3 | $0 (2024) |
| Lundbeck LLC | $41.49 | 2 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $40.63 | 1 | $0 (2017) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $40.13 | 2 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $33.21 | 2 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $25.90 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $522.51 | 30 | ABBVIE INC. ($142.12) |
| 2021 | $16.01 | 1 | Eisai Inc. ($16.01) |
| 2020 | $23.94 | 1 | Alkermes, Inc. ($23.94) |
| 2019 | $22.42 | 1 | Alkermes, Inc. ($22.42) |
| 2018 | $39.80 | 3 | Allergan Inc. ($24.11) |
| 2017 | $231.52 | 7 | Allergan Inc. ($127.81) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/04/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $10.85 | General |
| Category: Narcoplepsy | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: CNS | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $16.83 | General |
| Category: Narcoplepsy | ||||||
| 10/10/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $12.23 | General |
| Category: Narcoplepsy | ||||||
| 10/01/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: CNS | ||||||
| 09/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.09 | General |
| Category: PSYCHIATRY | ||||||
| 07/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Central Nervous System | ||||||
| 05/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.40 | General |
| Category: PSYCHIATRY | ||||||
| 05/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: PSYCHIATRY | ||||||
| 05/14/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: NEUROLOGY | ||||||
| 05/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $1.27 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Narcoplepsy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 106 | 133 | $17,410 | $5,550 |
| 2022 | 7 | 387 | 728 | $100,203 | $44,376 |
| 2021 | 7 | 333 | 681 | $92,455 | $44,697 |
| 2020 | 6 | 363 | 596 | $81,590 | $31,209 |
Total Patients
1,189
Total Services
2,138
Medicare Billing
$125,831
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 48 | 65 | $10,270 | $3,281 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 42 | 48 | $5,040 | $1,702 | 33.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 20 | $2,100 | $567.15 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 95 | 215 | $32,890 | $15,082 | 45.9% |
| 90837 | Psychotherapy, 1 hour | Facility | 2022 | 17 | 99 | $19,116 | $9,010 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 92 | 136 | $13,855 | $6,393 | 46.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 64 | $9,600 | $3,573 | 37.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 41 | 75 | $7,565 | $3,182 | 42.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 20 | 20 | $5,026 | $2,636 | 52.4% |
| 90834 | Psychotherapy, 45 minutes | Facility | 2022 | 11 | 37 | $5,023 | $2,314 | 46.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 38 | $3,800 | $1,307 | 34.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 31 | 44 | $3,328 | $879.80 | 26.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 96 | 248 | $37,200 | $16,732 | 45.0% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 15 | 91 | $17,800 | $9,122 | 51.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 88 | 137 | $13,700 | $6,288 | 45.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 49 | 81 | $8,100 | $4,860 | 60.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 29 | 29 | $7,250 | $3,889 | 53.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 40 | 63 | $4,725 | $2,061 | 43.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Office | 2021 | 16 | 32 | $3,680 | $1,745 | 47.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 95 | 226 | $33,900 | $13,112 | 38.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 88 | 147 | $14,700 | $5,527 | 37.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 57 | 80 | $12,000 | $4,188 | 34.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 37 | 37 | $10,500 | $3,997 | 38.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 44 | 51 | $5,100 | $1,653 | 32.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Office | 2020 | 11 | 21 | $2,415 | $1,177 | 48.7% |
About Dr. Aveekshit Tripathi, MD
Dr. Aveekshit Tripathi, MD is a Psychiatry healthcare provider based in Manhattan, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2009. The National Provider Identifier (NPI) number assigned to this provider is 1629206339.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aveekshit Tripathi, MD has received a total of $856.20 in payments from pharmaceutical and medical device companies, with $522.51 received in 2024. These payments were reported across 43 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($856.20).
As a Medicare-enrolled provider, Tripathi has provided services to 1,189 Medicare beneficiaries, totaling 2,138 services with total Medicare billing of $125,831. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Manhattan, KS
- Active Since 07/01/2009
- Last Updated 01/30/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1629206339
Products in Payments
- VRAYLAR (Drug) $282.76
- ARISTADA (Drug) $112.84
- REXULTI (Drug) $97.52
- WAKIX (Drug) $61.52
- LATUDA (Drug) $40.63
- Aristada 441 mg (Drug) $40.36
- CAPLYTA (Drug) $40.13
- Qelbree (Drug) $33.21
- XYWAV (Drug) $25.90
- QUILLICHEW ER (Drug) $20.92
- Auvelity (Drug) $20.14
- QUVIVIQ (Drug) $18.28
- TRINTELLIX (Drug) $17.85
- Austedo XR (Drug) $16.85
- Dayvigo (Drug) $16.01
- NAMZARIC (Drug) $11.28
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Manhattan
David Wichman, M.d, M.D
Psychiatry — Payments: $687,584
Psychiatry $687,584
Padma Lassi, M.d, M.D
Psychiatry — Payments: $1,655
Psychiatry $1,655
Grace Thomas, Md, MD
Psychiatry — Payments: $1,150
Psychiatry $1,150
Lakshika Ranaweera, Md, MD
Psychiatry — Payments: $418.80
Psychiatry $418.80
Krishan Lassi, Md, MD
Psychiatry — Payments: $222.46
Psychiatry $222.46
Dr. Paul Browde, M.d, M.D
Psychiatry — Payments: $214.16
Psychiatry $214.16